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Calculation Skills: Whitlow 
A whitlow, also known as a felon, is a closed space infection of the distal finger pulp (Franko and 
Abrams, 2013), commonly presenting as redness, tenderness and swelling (NICE, 2016).  McDonald 
et al (2011) state that the most common cause of infection to the hand area is staphylococcus 
aureus, and causes up to 80% of staphylococcal whitlows (NICE, 2016). Whitlows can also be caused 
by the herpes virus and are known as herpetic whitlows, with symptoms often also including 
blistering (NHS, 2017).  
No UK data is available but data from America suggests that staphylococcal whitlow (including 
paronychia), accounts for a third of hand infections, whilst the prevalence of herpetic whitlow is 2.4 
per 100,000 annually (NICE, 2017). 
 
Question 1 
Referring to table 1 and assuming that the American figures reflect the UK prevalence of herpetic 
whitlow, answer the following questions: 
(i) How many cases of staphylococcal whitlow would you expect to have seen in town E in 
2017?  
(ii) What would you expect the combined annual prevalence of herpetic whitlow to be in 
towns A, B and C to be? Round your answer up or down to the nearest whole number. 
(iii) In which town did 0.12% (rounded to two decimal points) of its population have a hand 
infection in 2017?  
Table 1: Incidence of hand infection 
UK Town Population 2017 cases of hand infection 
A 20,700 6 
B 6,700 3 
C 61,600 24 
D 37,700 18 
E 12,400 15 
 
 
 
 
 
 
 
 
 
Question 2 
NICE (2016) recommend the treatment regime identified in table 2, for staphylococcal whitlow.  
(i) Rupert, aged 21 years, has a staphylococcal whitlow and is prescribed flucloxacillin. He is 
prescribed the highest recommended dose. Both 250mg and 500mg capsules are 
available. Prescribing the fewest number of capsules, how many will need to be 
prescribed to complete the 7 day course? 
(ii) Sally is 4 years old and weighs 16kg. She is prescribed clarithromycin. What daily dose 
will Sally require? 
(iii) Abigail is a 30 year old breastfeeding mother who is allergic to penicillin. She is 
prescribed the lowest recommended dose of erythromycin for a whitlow. How much 
erythromycin (in grams) will she have taken on completion of the 10 day course? 
(iv) Tom is a 7kg infant, what is the daily dose of clarithromycin that he would need? 
 
Table 2: Recommended treatment regimen 
 Drug Age Dose 
First Line Flucloxacillin Adults & children over 
10 years 
250mg to 500mg, four 
times a day 
Children 2-10 years 125 mg to 250 mg, 
four times a day 
Children 1 month to 2 
years 
62.5 mg to 125 mg, 
four times a day 
Alternative if 
allergic to 
penicillin 
Clarithromycin Adults and children 
older than 12 years 
250 mg to 500 mg, 
twice daily 
Children 1 month to 12 
years according to 
body weight: 
 
less than 8 kg 7.5 mg per kg twice 
daily 
8–11 kg 62.5 mg twice daily 
12–19 kg 125 mg twice daily 
20–29 kg 187.5 mg twice daily 
30–40 kg 250 mg twice daily 
Alternative if 
allergic to 
penicillin / 
and if 
breastfeeding 
Erythromycin Adults and children 
older than 8 years 
250 mg to 500 mg, 
four times a day 
Children 2–8 years 250 mg, four times a 
day 
Children 1 month to 2 
years 
125 mg, four times a 
day 
 
Question 3 
Stan has a recurring herpetic whitlow and is to be treated with acyclovir as it is less than 48hours 
since the whitlow developed. The recommended dose is 200mg, five times daily, for five days but 
because he is immunosuppressed, the dose is to be doubled. Due to swallowing difficulties, he is 
prescribed oral suspension 200mg/5ml. 
(i) What amount of oral suspension is needed for a daily dose? 
(ii) How much oral suspension will need to be prescribed to enable the duration of the 
course to be extended by 40%? 
 
Question 4 
Public Health England (2015) wants to reduce antimicrobial resistance, with a reduction in the 
prescribing of antibiotics identified as one of the key strategies. They reported a 6.5% increase in 
antibiotic consumption over a 4 year period, expressed as a defined daily dose (DDD) per 1000 of the 
population. 
(i) Assuming the increase was consistent over the 4 year period, what percentage would 
the increase have been over the first 6 months? (rounded up or down to one decimal 
point). 
(ii) The defined daily dose (DDD) of antibiotics per 1000 people was 21.6 in 2011. What was 
the DDD in 2015? (rounded up or down to the nearest whole number) 
(iii) Assuming a 5% drop in antibiotic consumption from the 2015 DDD by 2020, what will 
the 2020 DDD be? 
 
Answers 
Question 1 
(i) 15 ÷ 3 = 5 
(ii) Prevalence rate = 2.4/100,000 or 0.0024/100 = 0.0024% 
Combined population = 89,000 
89,000 ÷ 100 x 0.0024 = 2.136  
annual prevalence = 2 (rounded down) 
(iii) Town A = 6 ÷ 20,700 x 100 = 0.03 
Town B = 3 ÷ 6,700 x 100 = 0.05 
Town C = 24 ÷ 61,600 x 100 = 0.04 
Town D = 18 ÷ 37,700 x 100 = 0.05 
Town E = 15 ÷ 12 400 x 100 = 0.12 
Answer is town E 
 
Question 2 
(i) Course = (5oomg x 4) x 7 = 14000mg  
14000 ÷ 500 = 28 capsules 
 
(ii) 125mg x 2 = 250mg 
 
(iii) Course = (250mg x 4) x 10 = 10000mg / 10g 
 (iv) (7.5 x 7) x 2 = 105mg 
 
Question 3 
Stan has a recurring herpetic whitlow and is to be treated with acyclovir as it is less than 48hours 
since the whitlow developed. The recommended dose is 200mg, five times daily, for five days but 
because he is immunosuppressed, the dose is to be doubled. Due to swallowing difficulties, he is 
prescribed oral suspension 200mg/5ml. 
(i) Daily dose = 400 mg x 5 = 2000 mg 
 
2000 00 x 5 = 50mls 
 
(ii) Normal course = 5 days  
40% =    _5_  x 40 = 2 days 
               100 
Extended course = 2 + 5  = 7 days 
50ml x 7 = 350ml 
 
Question 4 
Public Health England (2015) wants to reduce antimicrobial resistance, with a reduction in the 
prescribing of antibiotics identified as one of the key strategies. They reported a 6.5% increase in 
antibiotic consumption over a 4 year period. 
(i) 6.5% over 4 years = 0.8 % over 6 months (rounded down) 
(ii) (21.6 ÷ 100) x 6.5 = 1.404      21.6 + 1.404 = 23.04       23 (rounded down) 
(iii) 2015 = 23   5% = (23 ÷100) x 5 = 1.15    23 – 1.15 = 21.85 
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